ARE SECURITIES: Alexandria Real Estate Equities, Inc. Investors with Losses are Reminded to Contact BFA Law by January 26 Securities Fraud Class Action Deadline — Neutral
ARE Newsfile Corp — December 24, 2025New York, New York--(Newsfile Corp. - December 24, 2025) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit.
BRBR SECURITIES: BellRing Brands Investors with Losses are Reminded to Contact BFA Law about the Ongoing Securities Fraud Class Action Investigation — Neutral
BRBR Newsfile Corp — December 24, 2025New York, New York--(Newsfile Corp. - December 24, 2025) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit.
ITGR SECURITIES: Integer Holdings Corporation Investors with Losses are Reminded to Contact BFA Law by February 9 Securities Fraud Class Action Deadline — Neutral
ITGR Newsfile Corp — December 24, 2025New York, New York--(Newsfile Corp. - December 24, 2025) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Integer, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit.
JEF SECURITIES: Jefferies Financial Group Inc. Investors with Losses are Reminded to Contact BFA Law about the Ongoing Securities Fraud Class Action Investigation — Neutral
JEF Newsfile Corp — December 24, 2025New York, New York--(Newsfile Corp. - December 24, 2025) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal securities laws after SEC probe is revealed. If you invested in Jefferies or Point Bonita, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/jefferies-financial-group-inc-class-action.
Intuitive Surgical vs. Stryker: Which MedTech Stock Has More Upside? — Positive
ISRG SYK Zacks Investment Research — December 24, 2025Intuitive Surgical's robotics-first model, recurring revenue base, and margin leverage differentiate it from Stryker in terms of upside potential today.
QUBT Q3 Results Highlight Growing Adoption Across Quantum Platforms — Positive
QUBT Zacks Investment Research — December 24, 2025Quantum Computing's Q3 revenues rise to $384,000, driven by the launch of DIRAC-3 cloud access and the first quantum security order from a top U.S. bank, marking a key milestone.
KTOS vs. LMT: Which Defense Stock Is Better at Innovation? — Positive
KTOS LMT Zacks Investment Research — December 24, 2025Kratos Defense and Lockheed Martin benefit from Pentagon demand for advanced aerospace and defense systems.
MSTR stock at risk as a key MicroStrategy metric approaches a negative zone — Negative
MSTR Invezz — December 24, 2025The Strategy stock price continued its freefall this month and is now hovering at its lowest level since September last year. MSTR stock has plunged by over 70% from its highest level in 2024, even as the S&P 500 and the Nasdaq 100 indices jumped to a record high.
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings — Neutral
MAIA GlobeNewsWire — December 24, 2025Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that independent directors including Adelina Louie Ngar Yee and Stan V. Smith, Ph.D.
These 5 infrastructure stocks have more than tripled this year on the AI trade — Positive
LITE MU STX WDC CNBC — December 24, 2025Nvidia has been the biggest story in artificial intelligence infrastructure for three years, but in 2025 a number of data center stocks enjoyed steeper rallies. In addition to AI chips, fully operational data centers require memory, storage, fiber-optic cables and central processors.
Free streaming service Tubi is rivaling major players for viewership. Here's how it's winning — Positive
FOXA CNBC — December 24, 2025Free streaming platform Tubi, owned by Fox, reached profitability for the first time this year. It boasts 100 million monthly active users and a growing audience of millennial and Gen Z viewers.
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules — Neutral
DRMA Accesswire — December 24, 2025$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon the exercise in full of warrants SAN DIEGO, CA / ACCESS Newswire / December 24, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 2,022,062 shares of common stock (or pre-funded warrants in lieu thereof), series C warrants to purchase up to 2,022,062 shares of common stock and short-term series D warrants to purchase up to 2,022,062 shares of common …
Philip Morris International is transforming into a smoke-free leader, with 41% of revenue now from smoke-free products. PMI's adjusted diluted EPS has surged 16% YTD, driven by robust SFP adoption, pricing power, and margin expansion. Shares trade at a forward P/E of 18.2, about 4% below a fair value estimate of $158, implying 14% upside through 2026.
White Mountains Announces Final Results of Its Tender Offer — Neutral
WTM PRNewsWire — December 24, 2025HAMILTON, Bermuda , Dec. 24, 2025 /PRNewswire/ -- White Mountains Insurance Group, Ltd. (NYSE: WTM) announced today the final results of its "modified Dutch auction" tender offer.
Richtech Robotics Debuts Mobile Humanoid Robot Dex at CES 2026 — Neutral
RR GlobeNewsWire — December 24, 2025Features enhanced functionality of industrial humanoid robot Dex, integrating compounding real-world data, simulation training and a robotics framework to drive productivity and efficiencies in Commercial & Industrial LAS VEGAS, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics” or the “Company”), a U.S.-based provider of AI-driven robots operating in commercial and industrial environments, will demonstrate its robotics solution platform, presented by humanoid robot Dex, at CES 2026 being held from January 6 to 9, 2026, at the Las Vegas Convention Center (LVCC). Accelerated by the NVIDIA Jetson Thor, Dex is capable of operating in dynamic environments, …
2026 Could Be The Year Of The 2-ETF Portfolio: Here's A Simple One With SPY And BIL — Positive
SPY Seeking Alpha — December 24, 2025The stock market is getting simpler. Not in how to analyze it, but in the range of strategies that consistently work. That requires some rethinking about "asset allocation." Market structure changes, including algorithmic trading and index dominance, have diminished classic diversification benefits and stock-picking edges. For many investors, I think a combination of as few as one "offense" ETF, one "defense" ETF and a method to tactically allocate among them will be very competitive.
This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. — Positive
SNY Barrons — December 24, 2025Sanofi agrees to acquire Dynavax Technologies in an all-cash deal worth $2.2 billion in total equity value.
One of the most impressive growth stocks in recent years, Palantir (NASDAQ:PLTR) has also become among the most discussed names in the market.
3 Under-The-Radar Dividend Stocks to Buy on the Cheap — Neutral
CPB GIS PFE 24/7 Wall Street — December 24, 2025Dividend stocks have been under pressure in the past few years due to the broader economy's unpredictable swings.
Edible Garden to Start Shipping Pulp and Pickle Party to Western Beef — Neutral
EDBL GlobeNewsWire — December 24, 2025Strengthens Company Footprint In The New York Metropolitan Area Amid Continued Demand For Clean-Label, Better-For-You, Foods Strengthens Company Footprint In The New York Metropolitan Area Amid Continued Demand For Clean-Label, Better-For-You, Foods